Daily Roundup

Accent Group Ltd is facing headwinds as it navigates a challenging retail environment. The company reported a 1.9% decline in total sales for the first 19 weeks of FY27, with like-for-like sales dropping 3.9%. The deterioration has accelerated since August, with LFL sales now down 5.0% over that period. Owned retail sales fell 1.5% while wholesale slumped 5.1%. The retailer is blaming elevated fuel prices, rising interest rates, and weakening consumer confidence for the slowdown. On a brighter note, the company's gross margin has improved, and its 2030 Strategic Growth Plan initiatives are delivering benefits—though these gains have been overshadowed by the softer sales performance. As the crucial trading period approaches with Black Friday, Cyber Monday, Christmas, and back-to-school on the horizon, Accent Group will be hoping for a turnaround.

Smart Parking Ltd is telling a very different story. The parking technology company delivered a stellar FY26 performance, posting record revenue of $126.0 million—up 1.2% year-on-year—while adjusted EBITDA surged 37% to $30.8 million. A major win came through positive regulatory developments in the UK with a new Private Parking Code of Practice, which should provide a tailwind for future growth. The company is also making strategic moves in the U.S., with its CEO relocating there to drive long-term expansion. Looking ahead to FY27, Smart Parking expects a $5 million EBITDA benefit in the UK and anticipates Germany will break even during the year. The company remains on track to hit its FY27 targets with ongoing growth in sites and revenues.

In the medical technology space, Artrya Limited has secured a significant win that marks a turning point for its U.S. expansion. The Australian company has signed a five-year agreement with HonorHealth, a major Arizona health system serving approximately five million people. With a minimum contracted value of US$0.5 million, this deal represents Artrya's fifth U.S. customer and notably, its first inbound customer secured outside its foundation customers and SAPPHIRE study participants. This signals growing market awareness of Artrya's Salix® AI-powered cloud platform and demonstrates the company's ability to expand its customer acquisition channels organically in the United States.

Imricor Medical Systems is hitting its stride with a successful U.S. commercial launch now underway. The company kicked off operations with Rady Children's Hospital-San Diego as its first customer, establishing the country's first commercial interventional MR cardiac catheterization program. Children's Medical Center Dallas quickly followed as the second U.S. customer. Regulatory progress has also been solid, with FDA clearances for pediatric label expansions and acceptance of the manufacturing module for the Vision-MR Ablation Catheter. Strategic partnerships with Philips are opening doors to a broader customer base, and a new financing option called Imricor Finance is designed to ease hospital purchasing decisions. Financially, the company reported quarterly revenue of US$188,000, up a striking 437% from the prior year period. For the remainder of 2026, Imricor will focus on executing its U.S. launch and converting its hospital pipeline into NorthStar sales.

Ooh!Media Ltd has cleared another hurdle in its acquisition process. The company has received approval from the Foreign Investment Review Board for its proposed acquisition by OOH BidCo Pty. Ltd., owned by I Squared Capital. Shareholders have already signed off on the scheme, and while court approval and other conditions still need to be satisfied, this FIRB green light removes a significant regulatory obstacle.